These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 7631404

  • 21. Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients.
    Boothby AB, Tanner MK, Alswied A, Youngs D, Bribiesca Rodriguez J, Bikkani T, Cha N, Gernsheimer T, Gimferrer I, Hess JR, Sokol-Hessner L, Marivada S, Nash MG, Flegel WA, Vassallo RR, Stroncek DF, Tsang HC, Panch SR.
    Blood Adv; 2024 Sep 10; 8(17):4689-4699. PubMed ID: 39028936
    [Abstract] [Full Text] [Related]

  • 22. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
    Wong M, Narra R, Selim M, Zimmerman MA, Kim J, Padmanabhan A, Hong JC.
    J Surg Res; 2020 Nov 10; 255():99-105. PubMed ID: 32543385
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management.
    Panch SR, Guo L, Vassallo R.
    Blood Rev; 2023 Nov 10; 62():101135. PubMed ID: 37805287
    [Abstract] [Full Text] [Related]

  • 26. Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation--a prospective analysis.
    Ishida A, Handa M, Wakui M, Okamoto S, Kamakura M, Ikeda Y.
    Transfusion; 1998 Sep 10; 38(9):839-47. PubMed ID: 9738624
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Platelet transfusion refractoriness caused by a mismatch in HLA-C antigens.
    Saito S, Ota S, Seshimo H, Yamazaki Y, Nomura S, Ito T, Miki J, Ota M, Fukushima H, Maeda H.
    Transfusion; 2002 Mar 10; 42(3):302-8. PubMed ID: 11961234
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
    Bajpai M, Kaura B, Marwaha N, Kumari S, Sharma RR, Agnihotri SK.
    Natl Med J India; 2005 Mar 10; 18(3):134-6. PubMed ID: 16130614
    [Abstract] [Full Text] [Related]

  • 33. Absence of D alloimmunization in D- pediatric oncology patients receiving D-incompatible single-donor platelets.
    Molnar R, Johnson R, Sweat LT, Geiger TL.
    Transfusion; 2002 Feb 10; 42(2):177-82. PubMed ID: 11896332
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Systematic use of leukocyte-free blood components to prevent alloimmunization and platelet refractoriness in multitransfused children with cancer.
    Saarinen UM, Koskimies S, Myllylä G.
    Vox Sang; 1993 Feb 10; 65(4):286-92. PubMed ID: 8310680
    [Abstract] [Full Text] [Related]

  • 36. Response to random apheresis platelets versus HLA-selected platelets versus pooled platelets in HLA-sensitized patients.
    Gavva C, Barroso J, Gernsheimer T, Metcalf RA, Warner P, Pagano MB.
    Transfusion; 2019 Jul 10; 59(7):2276-2281. PubMed ID: 31032968
    [Abstract] [Full Text] [Related]

  • 37. Platelet transfusions: the problem of refractoriness.
    Murphy MF, Waters AH.
    Blood Rev; 1990 Mar 10; 4(1):16-24. PubMed ID: 2182145
    [Abstract] [Full Text] [Related]

  • 38. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S, Kavanagh JJ, Freedman RS, Folloder J, Currie LM, Bueso-Ramos C, Verschraegen CF, Narvios AB, Connor J, Hoots WK, Broemeling LD, Lichtiger B.
    Lancet; 2002 Jun 22; 359(9324):2145-52. PubMed ID: 12090979
    [Abstract] [Full Text] [Related]

  • 39. A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy.
    Blundell EL, Pamphilon DH, Fraser ID, Menitove JE, Greenwalt TJ, Snyder EL, Repucci AJ, Hedberg SL, Anderson JK, Buchholz DH, Kagen LR, Aster RH.
    Transfusion; 1996 Apr 22; 36(4):296-302. PubMed ID: 8623127
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.